Attached files
| file | filename |
|---|---|
| EX-99.2 - EX-99.2 - EAGLE PHARMACEUTICALS, INC. | a17-3593_1ex99d2.htm |
| EX-99.1 - EX-99.1 - EAGLE PHARMACEUTICALS, INC. | a17-3593_1ex99d1.htm |
| 8-K/A - 8-K/A - EAGLE PHARMACEUTICALS, INC. | a17-3593_18ka.htm |
Exhibit 23.1
Consent of Independent Auditors
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-202592) and Form S-8 (Nos. 333-213683, 333-206729, and 333-194056) of Eagle Pharmaceuticals, Inc. of our report dated February 1, 2017, relating to the financial statements of Arsia Therapeutics, Inc., which appears in this Form 8-K/A.
|
/s/ BDO USA, LLP |
|
|
|
|
|
February 1, 2017 |
|
|
|
|
|
Woodbridge, NJ |
|